Export: +91 9820402906   Domestic: +91 7710003340 | HR: +91 9137757219
Diclofenac Potassium and Paracetamol Tablets

Diclofenac Potassium & Paracetamol Tablets

Healthy Life Pharma

Combination Product:
Diclofenac Potassium + Paracetamol (Acetaminophen)
Common proposed strengths: Diclofenac Potassium 50 mg + Paracetamol 325 mg / 500 mg, subject to the specific registered formulation.

Other Diclofenac Sodium formulations supplied separately:
Diclofenac Sodium BP 25 mg film-coated tablet
Diclofenac Sodium BP/IP 50 mg enteric-coated tablet
Diclofenac Sodium BP 50 mg + Paracetamol BP 500 mg combination
Diclofenac Sodium BP 100 mg film-coated tablet

Usage: Relief of pain and inflammation where an NSAID/analgesic combination is clinically appropriate

Category: Analgesic / Painkiller Drugs

Therapeutic Category: NSAID / Analgesic / Arthritis

SKU: Diclofenac Potassium & Paracetamol Tablets

Categories: Contract Manufacturer, Formulations Exporter India, Manufacturing Pharmaceutical Company India, Pharmaceutical Exporter India, Pharmaceutical Formulations India, Tablets Manufacturer, WHO GMP Certified Formulations

Product Information

Diclofenac Potassium & Paracetamol Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.

For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.

Description

Diclofenac Potassium & Paracetamol Tablets

Manufactured by: Healthy Life Pharma Pvt. Ltd.
Exported by: Healthy Inc

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. manufactures Diclofenac and Paracetamol tablet formulations in India. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID), while Paracetamol (Acetaminophen) is an analgesic and antipyretic. Combination products may be used for short-term pain management where both components are clinically appropriate. Diclofenac potassium and diclofenac sodium are different salt forms and should not be described interchangeably; the exact salt and strength must match the registered product label.

2. Product Specifications

ParameterSpecification
Product NameDiclofenac Potassium & Paracetamol Tablets
Generic NameDiclofenac Potassium + Paracetamol (Acetaminophen)
Typical Combination StrengthDiclofenac Potassium 50mg + Paracetamol 325mg / 500mg, subject to registered formulation
Other Supplied Diclofenac FormsDiclofenac Sodium 25mg / 50mg / 100mg and Diclofenac Sodium 50mg + Paracetamol 500mg, as separate formulations
Dosage FormFilm-coated / other registered tablet presentation
StandardBP / IP / USP / approved in-house specification, as applicable
Therapeutic ClassNSAID + Analgesic / Antipyretic
Shelf LifeAccording to validated stability data and registered specification
PackagingBlister / Alu-Alu / authorized bulk pack according to registration

3. Manufacturing Technology

  • Formulation Control: The exact Diclofenac salt, Paracetamol strength, excipients and coating system are controlled according to the registered master formula.
  • Blend & Content Uniformity: Validated granulation/blending processes support consistent distribution of active ingredients.
  • Coating: Film or enteric coating is applied only where specified for the particular registered formulation; an enteric-coated Diclofenac Sodium product should not be assumed to represent a Diclofenac Potassium combination.
  • In-Process Controls: Tablet weight, hardness, friability, disintegration and other critical attributes are monitored against approved limits.

4. Quality Assurance

  • Assay & Uniformity: Both active ingredients are tested against the applicable finished-product specification.
  • Dissolution: Release testing follows the registered pharmacopoeial/in-house method and acceptance criteria rather than a universal release target.
  • Impurities: Relevant Diclofenac and Paracetamol impurities, including applicable degradation products, are controlled according to approved specifications.
  • Stability: Shelf life and storage conditions are supported by product-specific validated stability data.

5. Pharmacology and Clinical Use

Diclofenac reduces prostaglandin synthesis through cyclooxygenase inhibition, providing analgesic and anti-inflammatory effects. Paracetamol provides analgesic and antipyretic activity through predominantly central mechanisms.

  • Musculoskeletal Pain: May be used for selected acute painful inflammatory conditions when appropriate.
  • Dental / Post-Procedural Pain: May be prescribed for short-term pain where the benefits outweigh NSAID risks.
  • Other Pain: Use should be based on the specific approved indication, patient risk factors and local clinical guidance.
  • Important: Combination therapy does not eliminate Diclofenac's gastrointestinal/cardiovascular/renal risks or Paracetamol's dose-related liver toxicity.

6. Export and Regulatory Support

  • Dossier Support: CTD / ACTD or other applicable registration documentation where available.
  • Certificates: FSC, COPP and COA where applicable.
  • Private Label: Contract manufacturing can be supported subject to formulation approval and destination-country regulatory requirements.
  • Logistics: Air or sea shipment via FOB Mumbai / CIF according to applicable requirements.

7. Frequently Asked Questions

Q: Who manufactures Diclofenac & Paracetamol Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Diclofenac-based tablet formulations in India.

Q: Are Diclofenac Potassium and Diclofenac Sodium the same?
A: They contain the same active Diclofenac moiety but are different salt forms with different formulation characteristics. The salt stated on the registered label must be used; they should not be silently substituted in product specifications.

Q: Can other Paracetamol medicines be taken at the same time?
A: Taking multiple Paracetamol/Acetaminophen-containing products can unintentionally exceed the recommended total dose and cause serious liver injury. Check all medicine labels and follow clinician/pharmacist advice.

Q: Is this suitable for long-term pain treatment?
A: Diclofenac-containing products should generally be used at the lowest effective dose for the shortest appropriate duration. Longer treatment requires individualized assessment of gastrointestinal, cardiovascular, renal and other risks.


Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

  • Dose: Use the exact dose and duration stated in the registered product information or prescribed by a qualified clinician. Do not infer dosing from a different Diclofenac salt or strength.
  • Lowest Effective Exposure: Diclofenac should be used at the lowest effective dose for the shortest duration appropriate to the indication.
  • Paracetamol Total: Account for Paracetamol/Acetaminophen from all concurrent products to avoid accidental overdose.

9. Side Effects and Precautions

  • Gastrointestinal: Diclofenac can cause ulcers, bleeding or perforation, sometimes without warning. Risk is higher in older adults and with anticoagulants, corticosteroids, other NSAIDs or prior ulcer disease.
  • Cardiovascular: NSAIDs can increase the risk of serious cardiovascular thrombotic events. Avoid inappropriate use in patients with significant cardiovascular risk and follow product contraindications/warnings.
  • Renal: Diclofenac can impair kidney function, particularly in dehydration, kidney disease, heart failure or with interacting medicines.
  • Hepatic: Paracetamol overdose can cause severe or fatal liver injury; Diclofenac can also affect liver function.
  • Allergy / Asthma: Serious hypersensitivity and NSAID-associated bronchospasm can occur in susceptible patients.
  • Pregnancy: NSAID use during pregnancy has important gestational-age-specific risks and should follow current product labeling and clinician guidance.

10. Storage Instructions

  • Store below 25°C unless otherwise specified on the registered label.
  • Keep in a dry place and protect from excessive heat, light and moisture.
  • Keep in original packaging and out of reach of children.